LOS ANGELES, November 2, 2016 /PRNewswire/ --
CompuMed, Inc. (OTCPink: CMPD), a leader in providing Diagnostic Telemedicine, announced today that Loren Den Herder has joined the CompuMed Board of Directors. Additionally, Benjamin Large has resigned from the Board of Directors.
"We would like to thank Ben for his service to CompuMed shareholders these last two years and all his assistance as the Company has navigated through a leadership transition" stated David Pointer, CompuMed's Chairman.
Loren Den Herder brings more than 20 years of consulting experience particularly geared towards business software development as well as significant experience within industries served by key CompuMed customers. Loren is a member of the Project Management Institute and works developing business solutions for Moss Adams, LLP. "We are very glad to welcome him to the CompuMed Board of Directors", added Pointer.
About CompuMed, Inc.
CompuMed, Inc. (OTCPink: CMPD) Diagnostic Telemedicine services provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at http://www.compumedinc.com.
Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.
CompuMed, Inc., Investor Relations can be reached at firstname.lastname@example.org or (310) 258-5000 x117